Prasugrel Fails to Show Noninferiority to Clopidogrel in Stroke Prasugrel Fails to Show Noninferiority to Clopidogrel in Stroke

Despite being a more potent antiplatelet agent, prasugrel failed to show noninferiority to clopidogrel in reducing vascular events in stroke patients in a new phase 3 trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news